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Background/aim: One of the most common psychiatric disorders in children is attention-deficit/hyperactivity disorder, which is
treated extensively by methylphenidate. This study investigates the assessment of the effects of methylphenidate on histopathologic and
histomorphometric changes of the testes and serum levels of gonadotropin in mice.
Materials and methods: In this study, 36 adult male mice were used. After determining their body weights, the animals were divided
randomly into 2 experimental groups and 1 control group. The experimental groups received methylphenidate (2 and 10 mg kg–1 day–1)
via gavage for a period of 40 days. After evaluation of body weight, general anesthesia was used for taking blood samples from the
heart in order to measure testosterone and levels of gonadotropin in serum. For the purpose of weighing the bodies and measuring the
thickness of the germinal epithelium, the testes were removed and the possibility of any pathological changes was considered.
Results: The results showed that methylphenidate could decrease the thickness of the germinal epithelium and body weight significantly,
and could increase the levels of spermatogonia and serum gonadotropins and testosterone. Histopathological changes were also seen for
vascular dilatation and congestion in interstitial tissue.
Conclusion: Our findings demonstrated that administration of methylphenidate in adulthood may have an effect on spermatogenesis
due to the influence of gonadotropin hormones on testis function.
Key words: Methylphenidate, testis, morphometric, gonadotropin, histopathology

1. Introduction
Attention-deficit/hyperactivity disorder (ADHD) is
a neuropsychiatric disorder commonly diagnosed
during childhood, characterized by excessive levels of
inattentiveness, impulsivity, and hyperactivity (1). Ritalin
hydrochloride (methylphenidate hydrochloride), as a mild
central nervous system (CNS) stimulant, is available in the
form of 5, 10, and 20 mg tablets for oral administration;
Ritalin-SR is available as sustained-release tablets of 20
mg for oral administration. Although reported figures
vary considerably depending on diagnosis criteria,
socioeconomic status, geographic source of sample, and
sex, it is estimated that up to 3%–5% of elementary schoolage children meet the criteria for diagnosis of ADHD (2)
* Correspondence: simin_fazelipour@yahoo.com
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with a reported population prevalence of up to 12% (3).
Stimulant medications have been effective for the treatment
of ADHD (4). Methylphenidate (MPH) is the most
commonly prescribed therapeutic agent (5), accounting
for more than 90% of stimulants used for the management
of ADHD in the United States (6). Treatment duration for
the disorder can last for years (7), because longitudinal
studies report that ADHD symptoms can continue into
adulthood at a stimulated rate of persistence in up to 75%
of diagnosed children (8) and because stimulants remain
the preferred treatment for the management of adult
ADHD (9). Due to the extensive usage of MPH in ADHD
treatment in order to control unfavorable behaviors, many
investigations have been performed, including studies on
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change and disorder in hormone secretion (10). Another
study indicated that the body weight of male mice receiving
MPH was significantly decreased compared to the control
group (11). In another report, disorder in animal growth
following long-term administration of MPH was observed
(12). Another similar chemical substance, amphetamine,
also caused body weight reduction (13). It has also been
shown that cocaine, with a similar structure to MPH, can
induce body weight reduction and have harmful effects
on fertility (14). Moreover, the weight of the testis and
seminal vesicle in these mice decreased significantly. Some
changes in the weight of organs such as the brain, heart,
ovary, spleen, and prostate are also indicative of its effect on
different body organs (15). Little is known, however, about
the long-term effects of this drug on the reproductive axis
and thickness of the germinal epithelium.
Thus, regarding the high usage of MPH in children
and adults and the importance of genital glands in gamete
production, an evaluation of chronic usage of MPH on
morphometric changes in the testes of mice was the subject
of this study. The primary objective of our study was to
examine the effects of MPH on the male reproductive
axis, which undergoes many dynamic changes during
puberty. Moreover, the evaluation of histopathologic and
histomorphometric changes of testicular tissue following
consumption of MPH in male mice seemed to be necessary.
2. Materials and methods
2.1. Animals and experimental design
Thirty-six male mice of 90 days old were purchased from
the Raazi Institute in Iran. All animals were kept under
a 14/10-h light-dark cycle with a room temperature of
22–24 °C and relative humidity of 50%–65%. The animals
were acclimated to the laboratory for 1 week prior to
the commencement of the experiment and were fed ad
libitum with food and water throughout the experiment.
The male mice were randomly divided into 2 treatment
and 1 control groups (n = 12). The mice were initially
weighed. The treatment groups received 2 or 10 mg/kg
of hydrochloride methylphenidate solution (produced
by the Novartis Company) daily by gavage method,
using an animal feeding incubation needle. The control
group received only normal saline. The animals were
treated for 40 consecutive days. This administration
period was necessary to determine the effect of MPH
on sperm production because mice need a period of
35–40 days for a complete spermatogenic cycle including
spermatocytogenesis, meiosis, and spermiogenesis (16).
2.2. Sample collection
After treatment and being weighed again, the mice were
sacrificed using ether anesthesia at the end of 40 days.
Blood samples were collected from the heart via a sterile
injector containing heparin and centrifuged at 3000 rpm

for 5 min. Plasma was separated and then stored at –70 °C
until biochemical and hormonal analyses. This study was
reviewed and approved by the Institutional Animal Care
and Use Committee and was conducted in a facility that
is fully accredited by the Association for Assessment and
Accreditation of Laboratory Animal Care.
2.3. Testosterone and gonadotropin levels
The plasma testosterone and gonadotropin levels were
measured by the ELISA method using a DRG ELISA
testosterone and gonadotropin kit according to the kit
manufacturer’s instructions.
2.4. Histological examination
By opening the abdominal cavity, the testes were
removed in order to determine histomorphometric
and histopathologic changes. For determining the
changes in spermatogenic cell density, testis tissues
were fixed in Bouin’s solution for 48 h after washing in
physiologic serum. They were dehydrated through graded
concentrations of ethanol, embedded in paraffin wax,
sectioned at 5 µm of thicknesses, and stained with Mayer’s
hematoxylin and eosin (H&E). Twenty seminiferous
tubules (STs) were randomly examined per section, their
diameters and germinal cell layer thicknesses (from
the basal membrane towards the lumen of the tubule)
were measured using an ocular micrometer in a light
microscope, and the mean sizes of STs and germinal cell
layer thicknesses were calculated. Finally, photographs
were taken with a calibrated photomicroscope connected
to computer and equipped with Axiovision 4.8 software
and studied. A morphometric study of the diameter of
20 STs in each section was made. All of the sections were
studied by means of an Olympus light microscope with
multiple magnifications (400×). The thickness of the
germinal epithelium was measured and the number of
spermatogonia was counted.
2.5. Histopathological changes
For observation of the probable pathological changes
in tissue samples in the control group and the treatment
groups that received 2 or 10 mg/kg of MPH, a
histopathological study was carried out using the following
parameters: vacuolization of Sertoli cells, thickening of
basement membrane, hyperplasia of Leydig cells, fibrosis
of interstitial cells, and shedding of immature cells inside
the lumen of STs.
2.6. Statistical analysis
Data are presented as mean ± standard error of the mean
(SEM). The degree of significance was set at P < 0.05. Oneway analysis of variance and the post-hoc Tukey honestly
significant difference test were used to determine the
differences among the groups in terms of all the sperm
characteristics, biochemical parameters, and histological
findings. All the analyses were carried out using SPSS for
PC.
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3. Results
In the present study, the results on some aspects of
histological features, such as histomorphometry of
testes, and the biochemical factors of serum level of
gonadotropins and germinal cell counts in adolescence
have been considered. The results obtained from primary
and secondary weighing of the mice showed that the
difference between primary and secondary weights of
the treatment groups reflected a significant reduction in
comparison with the control group (P < 0.05; Table).
3.1. Histological and histomorphometric findings
Spermatogonia are composed of 2 types of dark and light
cells, which were both counted in this study. Concerning
the effect of MPH on the number of spermatogonia in
this study, there was a significant difference between the
groups receiving MPH and the control group. The group
that received 10 mg/kg of body weight showed a significant
increase, and the group that received 2 mg/kg of body
weight also showed an increase, although not significant,
when compared with the control group (Table). Another
aspect of this study was the measurement of the thickness of
the germinal epithelium, which is defined as the height from
the base of the spermatogonia to the nuclei of spermatozoa
in STs. In this study, in the experimental groups, there
was a significant decrease in the thickness of the germinal
epithelium compared to the control group (Table; Figures
1–3). Another factor in this study was the measurement of
the diameter of STs, in which no significant difference was
observed between the control and experimental groups.
3.2. Biochemical findings
Comparing the average level of testosterone in the
experimental groups with the control group, a reduction
was observed, which was significant in the group receiving

2 mg/kg of body weight compared with the control group
(Table). Concerning the level of luteinizing hormone (LH),
a significant increase was shown between the groups that
received 2 and 10 mg/kg of MPH compared with the control
group (P < 0.05; Table). Follicle-stimulating hormone
(FSH) was also measured and no significant difference was
observed between the control and experimental groups.
3.3. Histopathological findings
No significant histopathological changes were seen for
vacuolization of Sertoli cells, mature germ cell shedding, or
changes of Leydig cells, but we observed vascular dilatation
and congestion in interstitial tissue in the experimental
specimens compared with the control specimens.
4. Discussion
Methylphenidate hydrochloride is a stimulant for CNS with
a structure close to dextroamphetamine (17,18). MPH is an
isomer of amphetamine (19). The neuropharmacological
profile of MPH is also similar to that of cocaine (20). This
drug was first synthesized in 1944 and was used initially as
an analeptic for several types of barbiturate-induced coma,
and also in treatment of ADHD, but later it was used as a
drug to improve memory in depressed elderly patients, for
concentration in adults, and for patients with brain tumors.
Most of the studies using systemic MPH application
reported that it exhibits reinforcing effects. Humans who
were administered MPH systemically reported similarities
in the reinforcing effects of MPH to those of cocaine or
amphetamine. Moreover, MPH has a higher mortality rate
than cocaine and amphetamine when taken systemically
(21–26). In a study carried out on the effect of MPH on
the fertility of male mice, it was indicated that MPH could
significantly decrease fertility (16).

Table. Comparison of the average difference of body weight, diameter of STs, thickness of germinal epithelium, number of spermatogonia,
and levels of FSH, LH, and testosterone hormones in the groups receiving MPH and the control group at the end of the experiment.
The measurements from 12 animals are expressed as mean ± SEM values. Different superscript letters (a, b, c) in each row indicate a
significant difference at the level of P < 0.05.
Groups
Parameters

Experimental I,
2 mg/kg

Experimental II,
10 mg/kg

11.70 ± 0.80 a
40.92 ± 1.33 a

3.66 ± 1.0003 b

4.26 ± 0.81 b

47.25 ± 2.60 a

58.25 ± 1.60 b

Thickness of germinal epithelium (µm)

219.33 ± 19.15 a

154.13 ± 5.13 ab

184.60 ± 8.07 a

Diameter of STs (µm)

1333.54 ± 69.91 a

1377 ± 14.61 a

1448.89 ± 17.66 a

FSH

1.608 ± 0.1764 a

2.058 ± 0.1616 a

1.472 ± 0.1944 a

LH

0.1250 ± 0.0066a

0.6583 ± 0.04369 b

1.1758 ± 0.26096 c

Testosterone

69.81 ± 5.78 a

2.32 ± 0.32 b

14.33 ± 0.40 c

Body weight differences (g)
Number of spermatogonia (n)
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Control group
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Figure 1. A photograph of STs in the control group that shows
a- the thickness of germinal epithelium indicated by arrows in 2
tubules, b- spermatogonia, c- Leydig cells (H&E, 100×).

Figure 2. A photograph of several STs in the experimental groups
that received MPH that shows a- the thickness of germinal
epithelium in some tubules, b- spermatogonia, c- Leydig cells
(H&E, 100×).

Thus, regarding the importance of the genital system in
gamete production, and also the relatively small number of
studies on the effects of MPH on some parameters related
to the male genital system, more studies of its effects on
histomorphometric and histopathological aspects of
the testes and serum levels of the hormones related to
testicular function seem to be necessary. The animals
used for this experiment were adult male mice and the
doses of methylphenidate hydrochloride were 2 and 10
mg/kg of body weight, orally administered by gavage
method. The effect of MPH on body weight was such that
a significant decrease occurred in the groups that received
MPH at doses of 2 or 10 mg/kg of body weight daily for
40 days in comparison with the control group. Another

Figure 3. A photograph of several STs in the experimental groups
that received MPH that shows a- the thickness of germinal
epithelium, b- spermatogonia, c- Leydig cells (H&E, 100×).

survey on mice claimed that chronic usage of MPH can
induce a significant decrease in body weight (13). Other
research, on the weight of male mice of the breed B6C3F1
that received MPH chronically, demonstrated that there
was a significant decrease in the weight of the treatment
group compared with the control group, and a similar
result was deduced for the weights of testes and seminal
vesicles (11). In various research it has been shown that
reduction in body weight following administration of
MPH could be due to decreased appetite and lower food
consumption, or reduced absorption, which is directly
related to the body weight and affects animal growth
(23). In this study, it was seen that MPH could affect the
number of spermatogonia in STs by inducing a significant
increase in the experimental group receiving MPH at a
dose of 10 mg/kg of body weight. The group that received
MPH at the dose of 2 mg/kg of body weight showed an
increase in the number of spermatogonia compared with
the control group. A survey on mice aged from 30 to 44
days old revealed that using MPH as an intraperitoneal
injection with a dose of 2 mg kg–1 day–1 could have a
positive effect on testicular growth (10). Another result
of this investigation was a significant decreasing in
the thickness of the germinal epithelium in the group
that received MPH chronically at a dose of 2 mg/kg of
body weight. In the group that received MPH at a dose
of 10 mg/kg of body weight, there was also a decrease
compared with the control group. In a similar study of
the effect of MPH on spermatogenesis, it was claimed
that following the usage of MPH chronically by gavage
method at doses of 5 and 10 mg/kg of body weight daily,
the number of spermatids showed a significant reduction,
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which could be due to the increasing of apoptosis and
P52 gene expression through the use of MPH (27).
Considering the structural and functional similarities
of cocaine and MPH, a study showed that consumption
of cocaine hydrochloride at a dose of 15 mg/kg of body
weight at the ages of 3, 6, and 12 weeks for 28 days
induced apoptosis in germinal cells in Sprague-Dawley
rats. Investigations into activity of caspase 3 in germinal
cells under influence of cocaine have been done and
showed induced apoptosis (28). In this study, considering
the thickness of the germinal epithelium and apoptosis
of germinal cells by consumption of MPH or cocaine, it
might be concluded that MPH could have an effect on
the germinal cells via an influence on their inheritance
and inhibiting of cell division, thus inducing cessation
in the cell life cycle. A histomorphometric finding of
this study was the measurement of the diameter of STs,
in which no significant difference between the control
and experimental groups was observed, whereas some
other investigations claimed an effect of drugs and other
chemicals on the diameter of these tubules. In this regard,
the significant decreasing effect on the diameter of STs of
busulphan in the treatment of cancer should be mentioned
(29). In the present study, the testosterone serum levels in
experimental groups receiving MPH showed a significant
decrease compared with the control group. Such a
decrease with other chemicals has also been reported. In
relation to this, some studies on the effect of opium drugs
on testosterone serum level have shown a significant
decrease in experimental groups compared with the
control group (30). In a survey on testosterone secretion
in mice, it was shown that using diethylcarbamazine
daily at the dose of 200 mg/kg of body weight can cause a
significant decrease in testosterone secretion (31). In this
survey, LH serum level in experimental groups increased
compared with the control group. Another study of the
effect of MPH on LH serum level in female mice showed
no significant difference between the experimental
groups and the control group (23). Regarding the results
of studies of LH and testosterone serum levels and the
changes in these hormones, it can be deduced that there
might be a close relationship between the changes, and so
when considering a significant decrease in testosterone
serum level and a corresponding significant increase in
LH serum level, it might be concluded that LH serum
levels increase in order to compensate for decreasing
testosterone by promoting testosterone secretion through
their influence on the surface of Leydig cells, which
possess the receptors for this hormone.
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On the other hand, surveying the structure of
Leydig cells and noting a lack of any changes in their
cytoplasm for eosinophilic and granule specifications
in some specimens, it seems that, with regards to the
previous studies suggesting that the enzyme effective
for testosterone production is metabolized in the liver,
perhaps MPH inducing an increase in LH does not have
any negative effect on the rate of testosterone but, due
to metabolization of the enzyme, causes a reduction in
testosterone production. Additionally, a scattering of
the Leydig cells in some specimens of the experimental
groups could induce such a reduction. Thus, regarding the
results of this study, it might be deduced that a decrease in
testosterone production is not the result of LH reduction,
but is rather due to some factors such as the metabolization
of its producing enzyme in the liver and a scattering of the
Leydig cells. Confirming this is the level of FSH, which
in this study did not show any significant changes in the
experimental groups compared with the control group. It
can thus be claimed that perhaps MPH does not have any
negative effect on the pituitary gland and consequently on
gonadotropes. Accordingly, there was a study of the effect
of this drug on gonadotropes of female mice in which
the level of LH in pituitary glands showed a significant
increase (23). The effect of this drug chronically on testis
structure induces a significant increase in spermatogonia
but, due to its effect on their development, including
cell division and differentiation, it negatively impacts
spermatogenesis and spermiogenesis. Moreover, some
studies have shown that consumption of MPH for a short
period of time in adult mice could have an influence on
the enzyme inducing testosterone production, lead to it to
being metabolized, and thus decrease testosterone (10). In
this study, no pathological changes were observed between
the control and experimental groups in the observation
of histopathological changes in microscopic specimens
with regards to some parameters including vacuolization
of Sertoli cells, thickening of basement membrane,
hyperplasia of Leydig cells, fibrosis of interstitial cells, and
shedding of immature cells inside the lumen of STs. Some
degree of vascular congestion in the specimens of the
group receiving MPH at doses of 2 and 10 mg kg–1 daily–1
was observed.
By surveying testicular tissue in the experimental
groups, it was concluded that due to the use of this drug
in patients with ADHD and also in adults as an aid to
concentration, for which it is used by students, it should
be controlled carefully and it should only be available on
prescription. Psychiatrists should be advised, if possible, to
replace it with another medication.
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